Everest Medicines Signed a MoU with Shanghai Pharma Subsidiary to Advance the Commercialization of Xerava (eravacycline) in Mainla...
April 19, 2023
Singapore HSA Accepts NDA of Everest Medicines’ Nefecon for the Treatment of Primary IgA Nephropathy
April 6, 2023
Everest Medicines’ Xerava (eravacycline) Receives NMPA’s Approval for Complicated Intra-Abdominal Infections in Adult Patients
March 17, 2023
Everest Medicines and Calliditas Receives Priority Review for Nefecon in IgA Nephropathy for China
January 2, 2023
Everest Medicines Licensing Partner Pfizer Reports the US FDA and EMA’s Acceptance of NDA and MAA for Etrasimod in Ulcerative Coli...
December 22, 2022
Everest Medicines Receives the NMPA’s IND Approval for EVER001 to Treat Renal Diseases
September 26, 2022
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.